Examination Candidates definition

Examination Candidates means those persons who register with the Institute for any of its professional examinations and who thereby agree to comply with the required Examination Regulations. These examinations are -
Sample 1Sample 2Sample 3
Examination Candidates means a person or persons who are registered to sit for examinations; “Examination Fee” shall mean the fee payable for the provision and conducting of an examination by FPI; “FAIS Act” shall mean the Financial Advisory and Intermediary Services Act, No. 37 of 2002, as amended;
Sample 1Sample 2Sample 3

Examples of Examination Candidates in a sentence

  • Data of doctoral candidates who have not successfully completed their doctorate at the University of Rostock will be deleted immediately after exmatriculation or termination of their doctoral status, if the doctoral candidate has disagreed with the use of their data according to § 7 paragraph 3 of the Statutes for the Processing of Personal Data of Applicants, Current and Former Students, Examination Candidates and Doctoral Candidates at the University of Rostock.

  • The Santa Fe County Community Services Department is requesting proposals from qualified Offerors to design and implement a Program Evaluation.

  • All candidates are expected to comply with the MRCPsych Code of Conduct for Examination Candidates (including Applicants) – see section 16 below.Further rules and guidance regarding conduct during the examination and expectations of candidate, including technical specifications for the online exams will be issued to candidates prior to the examination date, and these documents will form part of the Eligibility Criteria & Regulations for the MRCPsych Examinations.

  • Upon registration for a CAIA Examination, Candidates have a revocable, non-exclusive, non-transferrable license to use these Exam-Related Materials for their own examination preparation only.

  • FRCEM – Format of Examination Candidates are required to have passed the qualifying examinations detailed further below in order to be eligible to sit the FRCEM components.

  • Preparing for the Clinical Phase of the Examination Candidates will be using the FSCJ Dental Hygiene Clinic.

  • Recommendation of the Certification Committee for Approval of Examination Candidates for the Uniform CPA Examination – A.R.S. § 32-723: 1.

  • Selected candidates will be required to undergo Medical test as per the advice of company Medical Officer.The shortlisted candidates will be inducted as per vacancies being decided to be filled in by the management subject to being found FIT in the Pre-Employment Medical Examination Candidates will have to bear the cost of the Pre-Employment Medical Examination(s), including any additional tests if required.

  • Medical Examination :Candidates recommended for appointment will have to pass the requisite medical fitness standards prescribed for the post to be identified by the Northern Railway Administration.

  • Professional Development: A Guideline for Members-in-Training, Examination Candidates, Students and Applicants.

Related to Examination Candidates

  • Examination Criteria means the loan classification criteria employed by, or any applicable regulations of, the Assuming Institution’s Chartering Authority at the time such action is taken, as such criteria may be amended from time to time.

  • Examination Period means the last ten reporting cycles including the reporting cycle in which the involuntary examination is commenced except for instruments evidencing ownership, or rights to them or funds paid toward the purchase of them, or any dividend, capital credit, profit, distribution, interest, or payment on principal or other sum, held or owed by a holder, including funds deposited with a fiscal agent or fiduciary for payment of them, or pertaining to debt of a publicly traded corporation.

  • Development Candidate means a Compound that meets the Development Candidate Criteria for the initiation of a Development Program for the treatment of CF, and which is the subject of a notice from Vertex to CFFT that Vertex intends to commence formal pre-clinical development of the Compound in the Field pursuant to the provisions of Section 3.1 hereof.

  • Product Candidate means any pharmaceutical product developed, manufactured and/or tested by or on behalf of the Company that has not received a Regulatory Authorization for commercial distribution other than in connection with pre-clinical or clinical trials.

  • Independent candidate means any candidate who claims not to be affiliated with a political party, and whose name has been certified on the office-type ballot at a general or special election through the filing of a statement of candidacy and nominating petition, as prescribed in section 3513.257 of the Revised Code.

  • Independent testing laboratory means an independent organization, accepted by the Contracting Officer, engaged to perform specific inspections or tests of the work, either at the site or elsewhere, and report the results of these inspections or tests.

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).

  • Qualifying Examination means examinations on the basis of which a candidate becomes eligible for admission or its equivalent examination;

  • Phase I Study means a study in humans which provides for the first introduction into humans of a product, conducted in healthy volunteers or patients to obtain information on product safety, tolerability, pharmacological activity or pharmacokinetics, as more fully defined in 21 C.F.R. § 312.21(a) (or the non-United States equivalent thereof).

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).

  • IND means an investigational new drug application filed with the FDA with respect to a Product, or an equivalent application filed with a Regulatory Authority in a country other than the United States to commence a clinical trial of pharmaceutical product.

  • Replacement Candidate means any Candidate Introduced by the Agency to the Client to fill the Engagement following the Introduction of another Candidate whose Engagement either did not commence or was terminated during the first 12 weeks of the Engagement;

  • Election campaign means any campaign in support of or in

  • Phase I Clinical Trial means a human clinical trial that is intended to initially evaluate the safety and/or pharmacological effect of a Product in subjects or that would otherwise satisfy requirements of 21 C.F.R. 312.21(a), or its foreign equivalent.

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Phase III Clinical Study means a trial involving administration of a Compound to sufficient numbers of human patients with the goal of establishing that the Compound is safe and efficacious for its intended use, to define warnings, precautions and adverse reactions that are associated with the drug or label expansion of such Compound, and to be considered as a pivotal study for submission of an NDA.

  • Medical examination means the preliminary assessment of a person by an authorized health worker or by a person under the direct supervision of the competent authority, to determine the person’s health status and potential public health risk to others, and may include the scrutiny of health documents, and a physical examination when justified by the circumstances of the individual case;

  • Phase II Study means a human clinical trial, for which the primary endpoints include a determination of dose ranges and/or a preliminary determination of efficacy in patients being studied as described in 21 C.F.R. § 312.21(b) (FDCA), as amended from time to time, and the foreign equivalent thereof.

  • Phase II Clinical Trial means a controlled human clinical study that would satisfy the requirements of 21 CFR 312.21(b), conducted to study the effectiveness and establish the dose range of a Product for a particular Indication in patients with the disease or condition under study, including a Phase IIA Clinical Study or Phase IIB Clinical Study.

  • Study means the investigation to be conducted in accordance with the Protocol.

  • Clinical Studies means human clinical trials for a Licensed Product and any other tests and studies for a Licensed Product in human subjects.

  • Field means all fields of use.

  • Phase IIb Clinical Trial means a clinical trial of a Product on sufficient numbers of patients that is designed to provide a preliminary determination of safety and efficacy of such Product in the target patient population over a range of doses and dose regimens.

  • Examination means an inquiry into a specific element of or process related to bills for services performed under this Agreement. Either Party (the “Requesting Party) may perform one (1) Audit per twelve (12) month period commencing with the Effective Date, with the assistance of the other Party, which will not be unreasonably withheld. The Audit period will include no more than the preceding twelve (12) month period as of the date of the Audit request. The Requesting Party may perform Examinations, as it deems necessary, with the assistance of the other Party, which will not be unreasonably withheld.

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.